Parvalbumin Interneurons of Central Amygdala Regulate the Negative Affective States and the Expression of Corticotrophin-Releasing Hormone During Morphine Withdrawal

Int J Neuropsychopharmacol. 2016 Dec 3;19(11):pyw060. doi: 10.1093/ijnp/pyw060. Print 2016 Nov.

Abstract

Background: The central nucleus of the amygdala (CeA) is a crucial component of the neuronal circuitry mediating aversive emotion. Its role in the negative affective states during drug withdrawal includes changes in opioidergic, GABAergic, and corticotropin-releasing factor neurotransmission. However, the modulation of the neurobiological interconnectivity in the CeA and its effects in the negative reinforcement of drug dependents are poorly understood.

Method: We performed electrophysiological recordings to assess the membrane excitability of parvalbumin (PV)+ interneurons in the CeA during chronic morphine withdrawal. We tested the morphine withdrawal-induced negative affective states, such as the aversive (assessed by conditioned place aversion), anxiety (assessed by elevated plus maze), and anhedonic-like (assessed by saccharin preference test) behaviors, as well as the mRNA level of corticotropin-releasing hormone (CRH) via optogenetic inhibition or activation of PV+ interneurons in the CeA.

Result: Chronic morphine withdrawal increased the firing rate of CeA PV+ interneurons. Optogenetic inhibition of the activity of CeA PV+ interneurons attenuated the morphine withdrawal-induced negative affective states, such as the aversive, anxiety, and anhedonic-like behaviors, while direct activation of CeA PV+ interneurons could trigger those negative affective-like behaviors. Optogenetic inhibition of the CeA PV+ interneurons during the morphine withdrawal significantly attenuated the elevated CRH mRNA level in the CeA.

Conclusion: The activity of PV+ interneurons in the CeA was up-regulated during chronic morphine withdrawal. The activation of PV+ interneurons during morphine withdrawal was crucial for the induction of the negative emotion and the up-regulation of CRH mRNA levels in the CeA.

Keywords: CRH; PV; central amygdala; morphine withdrawal; negative affective states.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Affect*
  • Animals
  • Anxiety / genetics
  • Anxiety / metabolism
  • Anxiety / physiopathology
  • Anxiety / psychology
  • Behavior, Animal*
  • Central Amygdaloid Nucleus / metabolism*
  • Central Amygdaloid Nucleus / physiopathology
  • Corticotropin-Releasing Hormone / genetics
  • Corticotropin-Releasing Hormone / metabolism*
  • Disease Models, Animal
  • Excitatory Postsynaptic Potentials
  • Feeding Behavior
  • Genotype
  • Interneurons / metabolism*
  • Maze Learning
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Miniature Postsynaptic Potentials
  • Morphine*
  • Optogenetics
  • Parvalbumins / genetics
  • Parvalbumins / metabolism*
  • Phenotype
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Saccharin / administration & dosage
  • Signal Transduction
  • Substance Withdrawal Syndrome / genetics
  • Substance Withdrawal Syndrome / metabolism*
  • Substance Withdrawal Syndrome / physiopathology
  • Substance Withdrawal Syndrome / psychology
  • Up-Regulation

Substances

  • Parvalbumins
  • RNA, Messenger
  • Morphine
  • Corticotropin-Releasing Hormone
  • Saccharin